MedPath

Effects of combined consumption of catechins and chlorogenic acids on postprandial glucose, insulin, incretin response and insulin sensitivity in healthy men: a randomized, double-blind, placebo-controlled crossover trial

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000039514
Lead Sponsor
Kao Corporation
Brief Summary

A significant difference was observed in the primary outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
11
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects having diabetes (2) Subjects who have a history or signs of a heart or cerebrovascular disease (3) Subjects having diabetes, a liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (4) Subjects who take an antidiabetic drug or antihyperlipidemic drug (5) Subjects having thyroid deficiency (6) Subjects who have a smoking habit (7) Heavy drinker (8) Subjects who have donated over 200 mL of blood within the last one month prior to the current study or over 400 mL of blood within the last three months prior to the study (9) Subjects who have severe anemia (Hb <=7 g/dL) (10) Subjects who have allergic reaction to food (11) Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath